SCHEMBL25770

SCHEMBL25770

COc1ccc(CO[C]=O)c([N+](=O)[O-])c1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
POLB P06746 2/20 0.41
HTT P42858 2/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 4/20 0.40
KDM4E B2RXH2 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
TRPV1 Q8NER1 1/20 0.39
PKM P14618 1/20 0.38
MAPT P10636 4/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28527757 0.82 ALDH1A1 (0.42) ALDH1A1POLBHTTLMNASMN1; SMN2
SCHEMBL5373510 0.82 KDM4E (0.45) ALDH1A1POLBHTTLMNASMN1; SMN2
SCHEMBL16033385 0.82 ALDH1A1 (0.42) ALDH1A1POLBHTTLMNASMN1; SMN2
SCHEMBL215343 0.82 TDP1 (0.46) ALDH1A1POLBHTTLMNASMN1; SMN2
SCHEMBL18138425 0.80 TDP1 (0.45) ALDH1A1POLBHTTLMNASMN1; SMN2
SCHEMBL6436367 0.80 ALDH1A1 (0.41) ALDH1A1POLBHTTLMNASMN1; SMN2
SCHEMBL2027829 0.80 AOC3 (0.46) ALDH1A1POLBLMNASMN1; SMN2TDP1
SCHEMBL5964869 0.79 KDM4E (0.44) ALDH1A1POLBHTTLMNASMN1; SMN2
SCHEMBL11748681 0.79 KDM4E (0.44) ALDH1A1POLBHTTLMNASMN1; SMN2
SCHEMBL8950197 0.79 KDM4E (0.47) ALDH1A1POLBHTTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4679 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4378944-A1 COMPOUND HAVING PHOTOCLEAVABLE SITE, LINKER, AND SCREENING METHOD USING SAME CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-06-05 EP claimed
WO-2024044657-A1 BIOCATALYSTS AND METHODS THEREOF TESARO, INC. (US) 2024-02-29 WO claimed
WO-2024038426-A1 LIQUID-LIQUID PHASE SEPARATION (LLPS)-BASED COMPARTMENTS COMPRISING A SHORT PEPTIDE AND AN ANIONIC POLYMER RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2024-02-22 WO claimed
EP-4013420-B1 METHOD OF BLOCKING OR AMELIORATING CYTOKINE RELEASE SYNDROME RIGEL PHARMACEUTICALS INC (US) 2023-11-01 EP claimed
EP-3838901-B1 COMPOUND FOR TREATMENT OF RABIES AND METHOD FOR TREATMENT OF RABIES IRIMAJIRI THERAPEUTICS INC (JP) 2023-09-27 EP claimed
EP-4204445-A2 ASSAYS AND REAGENTS FOR CHARACTERIZATION OF MHCI PEPTIDE BINDING GENENTECH, INC. (US) 2023-07-05 EP claimed
US-11673912-B2 Continuous, solvent-free and non-enzymatic peptide synthesis by reactive extrusion CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2023-06-13 US claimed
EP-3694853-B1 PROCESS FOR THE PREPARATION OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6-DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CARBONITRILE ARRAY BIOPHARMA INC (US) 2023-05-17 EP claimed
WO-2023054636-A1 COMPOUND HAVING PHOTOCLEAVABLE SITE, LINKER, AND SCREENING METHOD USING SAME 中外製薬株式会社 2023-04-06 WO claimed
CN-115916791-A Crystalline RET inhibitors 罗索肿瘤学公司 2023-04-04 CN claimed
WO-2000001711-A1 REUSABLE SOLID SUPPORT FOR OLIGONUCLEOTIDE SYNTHESIS UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 2000-01-13 WO claimed
EP-0920440-A2 DETECTION OF NUCLEIC ACID SEQUENCE DIFFERENCES USING THE LIGASE DETECTION REACTION WITH ADDRESSABLE ARRAYS CORNELL RESEARCH FOUNDATION, INC. (US) 1999-06-09 EP claimed
WO-1997031256-A2 DETECTION OF NUCLEIC ACID SEQUENCE DIFFERENCES USING THE LIGASE DETECTION REACTION WITH ADDRESSABLE ARRAYS CORNELL RESEARCH FOUNDATION, INC. (US) 1997-08-28 WO claimed
US-5482867-A Spatially-addressable immobilization of anti-ligands on surfaces AFFYMAX TECHNOLOGIES N.V. (NL) 1996-01-09 US claimed
US-5451683-A Spatially-addressable immobilization of anti-ligands on surfaces AFFYMAX TECHNOLOGIES N.V. 1995-09-19 US claimed
US-5405783-A Removing photoremovable protective group from region of substrate, contacting with protected amino acid, repeating to form peptide AFFYMAX TECHNOLOGIES N.V. (AN) 1995-04-11 US claimed
US-5252743-A Using cage binding compound AFFYMAX TECHNOLOGIES N.V. (NL) 1993-10-12 US claimed
EP-0502060-A4 SPATIALLY-ADDRESSABLE IMMOBILIZATION OF ANTI-LIGANDS ON SURFACES 1993-05-05 EP claimed
EP-0502060-A1 SPATIALLY-ADDRESSABLE IMMOBILIZATION OF ANTI-LIGANDS ON SURFACES AFFYMAX TECHNOLOGIES N.V. (AN) 1992-09-09 EP claimed
WO-1991007087-A1 SPATIALLY-ADDRESSABLE IMMOBILIZATION OF ANTI-LIGANDS ON SURFACES AFFYMAX TECHNOLOGIES N.V. (AN) 1991-05-30 WO claimed